The trademark application NEXPIRA was filed by TEVA Pharmaceuticals Europe B.V., a corporation established under the laws of the Kingdom of the Netherlands (the "Applicant"). The application was published for oppositions on September 23, 2015, and it was registered by office on January 10, 2016 without any oppositions.
The application was filed in English (French was selected as the second language).
The renewal of the trademark was recorded by the office on January 8, 2025.
Appointment and Replacement of representative of the trademark registration was recorded on July 29, 2020. Change of name and professional address of the trademark registration was recorded on August 31, 2020.